Kraig Labs Ships First Commercial Spider Silk Order in Milestone

Kraig Labs (OTCQB: KBLB) has shipped its first commercial order of spider silk, a development the company is calling its most significant commercialization milestone to date. The biotech firm, which has spent years developing engineered spider silk using transgenic silkworms, said the shipment signals that its proprietary fiber is ready to move from laboratory production into real-world commercial applications.

The order is headed to a performance brand that will put the material through practical testing, according to the company. Spider silk is widely regarded in materials science circles as one of the strongest and most elastic natural fibers known, with potential applications spanning sporting goods, apparel, medical devices, and defense. Kraig Labs has positioned itself as a pioneer in producing the fiber at commercial scale — a challenge that has eluded researchers for decades.

Read more Haynes Construction to Renovate Boutique Plymouth Waterfront Hotel →

The shipment represents a critical inflection point for Kraig Labs, which trades on the OTCQB venture market. For a small-cap biotech, transitioning from product development to revenue-generating commercial orders is a key proof-of-concept moment that can attract broader investor and industry attention. The company has not disclosed the financial terms of the order or the identity of the performance brand involved.

Spider silk's commercial potential has long been acknowledged by the materials industry, but scaling production has historically been the central barrier. Unlike silkworms, spiders are territorial and difficult to farm, making Kraig Labs' transgenic silkworm approach — engineering worms to produce spider silk proteins — a potentially transformative solution to that supply problem.

Continue reading at GlobeNewswire - Industry News on Financial Services.